U.S., Jan. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06790381) titled 'Effect of Biological Sex on Multimodal Biomarkers of Disease Progression in Patients with Parkinson's Disease' on Jan. 10.
Brief Summary: The GENDERIZE-PD study is a research project to understand how biological sex affects the progression of Parkinson's disease (PD). PD is a brain disorder that causes both movement and non-movement symptoms. Researchers aim to identify differences between men and women in how the disease progresses and in the biomarkers (biological indicators) related to the condition.
Study Goals:
Identify differences by sex in how PD develops and progresses, using clinical assessments, brain scans, and blood te...